Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 342
Infectious Diseases Drugs 245
Vaccines 218
Endocrine and Metabolic Disorders Drugs 176
Animal Healthcare/Veterinary 166
Drug Discovery 165
Immune Disorders Drugs 158
Women's Health 138
Central Nervous System Drugs 134
Cardiovascular Drugs 127
Clinical Trials 121
Musculoskeletal Disorders Drugs 107
Animal Pharmaceuticals 104
Pharmaceuticals 98
Respiratory Drugs 92
Biopharmaceuticals 90
Liver and Kidney Disorders Drugs 74
Oncology 72
Sexual and Reproductive Health Drugs 72
Allergy and Immunology 69
Diabetes Drugs 61
Genomics 60
Drug Delivery 56
Biotechnology 55
Gastrointestinal Drugs 55
Antibiotics 55
Enzymes 53
Optical Disorders Drugs 44
Skin Cancer Drugs 43
Dermatological Drugs 42
Analgesics 41
Brain Cancer Drugs 40
Diagnostics 40
Pulmonary Medicine 39
Hematological Drugs 37
Pharmaceutical Intermediates 35
Lymphoma Drugs 35
Biosimilars and Biosuperiors 35
Infusions and Injectables 32
Cancer Vaccines 32
Pharmaceutical Manufacturing 32
Healthcare Services 30
Lung Cancer Drugs 29
Optical 28
Liver Cancer Drugs 27
Infectious Disease Testing 26
Over the Counter (OTC) Drugs 26
Urological Disorders Drugs 26
Prostate Cancer Drugs 25
Biomarkers 23
Leukemia Drugs 22
Neurology 21
Medical Devices 20
HIV/AIDS Drugs 20
Asthma Drugs 20
Colon Cancer Drugs 19
Cervical Cancer Drugs 19
Cardiology 19
Breast Cancer Drugs 18
Inhalers and Nebulisers 18
Mental Disorders Drugs 18
E-Healthcare 17
Dermatology 17
Immunosuppressive Drugs 17
Hematology 15
Pancreatic Cancer Drugs 15
Allergy Drugs 15
Ovarian Cancer Drugs 14
Bladder Cancer Drugs 14
Vitamins and Dietary Supplements 14
Psoriasis Drugs 14
Generic Drugs 13
Fertility Services 13
Respiratory Devices 13
Alzheimer's Disease Drugs 13
Drugs by Therapeutic Area 12
Gastroenterology 12
Urology and Nephrology 11
Transdermal and Transmucosal Drug Delivery 11
Kidney Cancer Drugs 11
Pediatrics 11
Nanomedicine 10
Anti-Obesity Drugs 10
In Vitro Diagnostics 9
Thyroid Cancer Drugs 9
Uterine Cancer Drugs 9
Mental Health 8
Other Healthcare Facilities 8
Company Reports 7
Anesthetic Drugs 7
Laboratory Equipment 7
Bronchitis Drugs 7
Therapeutic Area 6
Hepatology 6
Cough and Cold Drugs 6
Endocrinology 6
Pharmacoeconomics 5
Bioinformatics 5
Healthcare 5
Diabetes Devices 5
Needles and Syringes 5
Proteomics 4
Addiction Disorders Drugs 3
Cardiovascular Devices 3
Dental 3
Blood Banking 3
Hospital Management 3
Surgical Procedures 3
Molecular Diagnostics 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Patient Monitoring Equipment 2
Laboratory Testing 2
Managed Care 2
Mammography 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Maternal and Neonatal Care 2
Acne Drugs 2
Orthopedic Devices 1
Glucose Testing 1
Dialysis 1
Coagulation and Hemostasis Testing 1
Wound Care 1
Stem Cells 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Clinical Therapies 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

3,360 Results (Page 33 of 168)
- Relevance
  Sort by

Uveal Melanoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1764EUR$2,000USD£1,521GBP

Insulin Pen Market

 Report
February 2024
78 Pages
Global

From

€2602EUR$2,950USD£2,244GBP

Biologic Therapeutic Drugs: Technologies and Global Markets

 Report
May 2025
170 Pages
Global

From

€4101EUR$4,650USD£3,537GBP

Idiopathic Pulmonary Fibrosis Treatment Market Report and Forecast 2023-2031

 Report
May 2023
160 Pages
Global

From

€4365EUR$4,949USD£3,765GBP

Acute Ischemic Stroke Diagnosis and Treatment - Global Strategic Business Report

 Report
July 2025
194 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Diabetes Drugs - Global Strategic Business Report

 Report
July 2025
196 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

 Report
September 2021
52 Pages
Global

From

€4405EUR$4,995USD£3,800GBP

Generic Injectables Market by Dimension Query Chat Segmentation - Global Forecast to 2030

 Report
May 2025
188 Pages
Global

From

€3126EUR$3,545USD£2,697GBP

€3474EUR$3,939USD£2,996GBP

Human Immunodeficiency Virus Type-1 (HIV-1) - Market Insight, Epidemiology and Market Forecast -2032

 Report
January 2022
200 Pages
Global

From

€6614EUR$7,500USD£5,705GBP

Autoimmune Collaboration and Licensing Deals 2016-2025

 Report
April 2025
500 Pages +
Global

From

€3523EUR$3,995USD£3,039GBP

H1N1 Vaccines - Global Strategic Business Report

 Report
July 2025
268 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

Monkeypox Vaccine and Treatment - Global Strategic Business Report

 Report
July 2025
455 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

Brucellosis Vaccines - Global Strategic Business Report

 Report
July 2025
276 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

Combination Vaccines - Global Strategic Business Report

 Report
July 2025
373 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

Live Attenuated Vaccines - Global Strategic Business Report

 Report
July 2025
563 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

Ruminant Vaccines - Global Strategic Business Report

 Report
July 2025
563 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

Oral Typhoid Vaccines - Global Strategic Business Report

 Report
July 2025
183 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

DNA Vaccines - Global Strategic Business Report

 Report
July 2025
171 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

Bacterial Vaccines - Global Strategic Business Report

 Report
July 2025
490 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

Adult Vaccines - Global Strategic Business Report

 Report
July 2025
377 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

3,360 Results (Page 33 of 168)
- 1
- 31
- 32
- 33
- 34
- 35

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.